title: Transient neurotoxicity associated with FK506: MR findings.
abstract: We report a patient presenting with transient neurotoxicity who developed edema in the cerebral and cerebellar cortex following bone marrow transplant and administration of FK506, a widely used immunosuppresive agent.
authors.affiliation: Department of Radiology, Akita UNiversity School of Medicine, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Tomura
authors.forename: R
authors.initials: R
authors.lastname: Kurosawa
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.forename: J
authors.initials: J
authors.lastname: Watarai
authors.forename: O
authors.initials: O
authors.lastname: Takeda
authors.forename: A
authors.initials: A
authors.lastname: Watanabe
authors.forename: G
authors.initials: G
authors.lastname: Takada
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001929:Brain Edema / Q000139:chemically induced* / Q000175:diagnosis; D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000175:diagnosis; D002540:Cerebral Cortex / Q000187:drug effects* / Q000473:pathology; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000628:therapy; D012640:Seizures / Q000139:chemically induced; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus